Delivery Order 75N95023D00021-75N98026F00001
Award Date 9/1/26
Potential Completion Date 8/31/27
Potential Value $136K
Funding Federal Agency
Contracting Federal Agency
Ultimate Awardee
Not listed NAICS Category
Set-Aside Type
Total Small Business
Federal Contract Vehicle
- Not listed
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
St Charles, MO, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The National Institute on Drug Abuse issued a $249,093.62 delivery order to Eurofins Discovery Services North America, LLC on September 21, 2025, under a Total Small Business set-aside for receptor profile screening. The order covers a period of performance from September 21, 2025 through September 20, 2027, with a firm fixed price structure. Place of performance is St. Charles, MO. Eurofins Discovery Services North America, LLC is a foreign-owned contract research organization specializing in...
- The National Institute on Drug Abuse issued a delivery order to Eurofins Discovery Services North America, LLC on September 26, 2023, with a ceiling value of $141,140.16 under a Total Small Business set-aside for receptor binding and predictive toxicology services. The order was issued under a $5 million single-award IDIQ with NIDA for receptor binding and predictive toxicology services through September 2028. Place of performance is Bethesda, MD. The period of performance runs from September...
- This is a $132,771.58 firm-fixed-price delivery order contract awarded by the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health (NIH), to Eurofins Discovery Services North America, LLC, a foreign-owned for-profit contract research organization. The contract is for receptor profile screening services in support of NIDA's drug abuse research programs. It has a period of performance from June 25, 2025 to June 24, 2026. The contract is not set aside for any small...
- This is a task order award under the National Institute on Drug Abuse's (NIDA) IDIQ contract No. HHSN271201800024I for receptor binding and predictive toxicology services. The award, valued at $291,884.01, was issued to Eurofins Discovery Services North America, LLC, a foreign-owned for-profit contract research organization. The task order is for work described under the NIDA contract with a period of performance from April 3, 2020 to April 2, 2021. The contract was awarded on a firm-fixed-price...
- The National Institute on Drug Abuse issued a delivery order to Technical Resources International, Inc., a minority-owned, woman-owned, and Hispanic American-owned small business, with a ceiling value of $11,400 on June 5, 2026. The order is issued under NIDA's $2.5 million IDV for pharmacokinetic analysis support. This delivery order covers Task Order 4, Pharmacokinetic Analysis Resource Center, Phase III Protocol (STP7), with performance in Westlake, MD from June 5, 2026 through March 4, 2027....
- The National Institute on Drug Abuse issued a delivery order to Technical Resources International, Inc., a minority-owned, woman-owned, Hispanic American-owned small business, on July 23, 2025, with a ceiling value of $36,099.00 under its single-award pharmacokinetic analysis and clinical pharmacology IDC (awarded May 2025, through May 2030). The order supports the Pharmacokinetic Analysis Resource Center, providing other support services. Place of performance is Westlake, MD. The initial period...
- The National Institute on Drug Abuse issued a delivery order to Technical Resources International, Inc., a minority-owned, woman-owned, Hispanic American-owned small business, on July 23, 2025, under its single-award indefinite delivery contract (N01DA-25-8947) for pharmacokinetic analysis and clinical pharmacology support. The order carries a ceiling value of $11,079.00 and runs through July 31, 2027. The parent IDC, valued at $2.5 million and awarded in May 2025, supports the Pharmacokinetic...
- This is a $140,748 firm fixed price delivery order awarded by the Department of Health and Human Services' National Institutes of Health National Institute on Drug Abuse to Eurofins Panlabs, Inc. for receptor binding and predictive toxicology services. The work will be performed in Weldon Spring, Missouri and is not associated with any set-aside designation. Eurofins Panlabs, Inc. is a foreign-owned for-profit contract research organization that has previously provided analytical chemistry,...
- The National Institute on Drug Abuse issued a delivery order to Mriglobal (doing business as Midwest Research Institute) on July 20, 2026, with a ceiling value of $382,839, under a cost-plus-fixed-fee pricing structure for Phase 1 single ascending dose pharmacokinetics study analytical services. The order runs through January 19, 2028. Place of performance is Kansas City, Missouri. This task order (DAP-NCAP-00000009) supports the Analytical Services Center for Medications Development, part of...
- <p>The National Institute on Drug Abuse issued a $332,178 delivery order to Total Trials, Inc. on September 20, 2023, under the CARRRP (Cooperative Agreement Research Response Program) task area framework for research support services.</p> <p>Place of performance is North Bethesda, MD. The order carries a cost-plus-fixed-fee pricing structure with an ultimate completion date of July 19, 2027. No set-aside was used. The ceiling value is $332,178.</p>